Treatment for MPS II is available in the form of enzyme replacement therapy (ERT) with recombinant human I2S (idursulfase; marketed as ELAPRASE®, Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts).24 Here, IDS is linked to mucopolysaccharidosis type 2.